Search

everythinglearnresearchcommunity

for

Search:↓

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

IGF-1 injections help mice grow more hair by increasing cell growth and blocking a hair growth inhibitor.

Parental socioeconomic status doesn't improve dietary habits or reduce disease severity in children with sickle cell disease.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

A new method was developed to accurately measure enzyme activity related to prostate health.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Some drugs may help treat both COVID-19 and radiation injury.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Ruxolitinib cream may help treat severe hair loss in children.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

The method increases stem-like cells for better skin regeneration.

Ebastine may help regrow hair in alopecia areata patients.

Blocking LFA-1 prevents hair loss in mice.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Gut bacteria differences may help diagnose and treat Alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.